Leap Therapeutics
Xieyang Jia is an experienced professional in the field of statistics and biostatistics, currently serving as Senior Director at Leap Therapeutics since May 2023. Prior to this role, Xieyang held various positions at Merck, including Director and Associate Principal Scientist from June 2018 to May 2023, and worked as a Senior Biostatistician at the New Jersey Institute of Technology from September 2013 to May 2018. Xieyang also gained practical experience as a Teaching Assistant at the New Jersey Institute of Technology and as a Biostatistics Intern at Janssen Inc. in 2016. Xieyang Jia holds a Ph.D. in Statistics from the New Jersey Institute of Technology and a Bachelor's Degree in Public Health from Fudan University.
This person is not in any teams
This person is not in any offices
Leap Therapeutics
1 followers
Leap Therapeutics (NASDAQ: LPTX) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research.